Boston Therapeutics Inc.

The company just got the permission to submit PAZAMET as Abriviation New Drug Application with the FDA with no additional clinical trials.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded August 2009
  • Employees 7
  • Website bostonti.com

Company Summary

Boston Therapeutics Inc. develped an anti diabetic drug called PAZAMET and a food supplement called SUGARDOWN to prevent post meal elevation of blood glucose for pre diabetics and diabetics of 400,000,000 people world wide.

Team

Advisors

  • Sayfart Shaw
    Lawyer
    Unconfirmed
    Macladery
    Accountant
    Unconfirmed

Previous Investors

  • Self funded
    Unconfirmed
    100 individual investors
    Unconfirmed
    Advance Pharmaceuticals Inc.
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free